OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

GIPR/GLP-1R dual agonist therapies for diabetes and weight loss—chemistry, physiology, and clinical applications
Jonathan E. Campbell, Timo D. Müller, Brian Finan, et al.
Cell Metabolism (2023) Vol. 35, Iss. 9, pp. 1519-1529
Open Access | Times Cited: 56

Showing 26-50 of 56 citing articles:

Human brown fat and metabolic disease: a heated debate
Rana K. Gupta
Journal of Clinical Investigation (2023) Vol. 133, Iss. 23
Open Access | Times Cited: 6

Paradigm Shift in the Management of Metabolic Diseases—Next-Generation Incretin Therapy
Bo Åhrén
Endocrinology (2023) Vol. 164, Iss. 12
Closed Access | Times Cited: 5

Design of a novel long-acting dual GLP-1/GIP receptor agonist
Yuanzhen Dong, Jinhua Zhang, Hongjiang Xu, et al.
Bioorganic & Medicinal Chemistry (2024) Vol. 100, pp. 117630-117630
Closed Access | Times Cited: 1

Duodenal enteroendocrine cells and GIP as treatment targets for obesity and type 2 diabetes
Clifford J. Bailey, Peter R. Flatt
Peptides (2024) Vol. 174, pp. 171168-171168
Closed Access | Times Cited: 1

Multifunctional host-defense peptides isolated from skin secretions of the banana tree dwelling frog Boana platanera (Hylidae; Hylinae)
J. Michael Conlon, Ananyaa Sridhar, Dawood Khan, et al.
Biochimie (2024) Vol. 223, pp. 23-30
Open Access | Times Cited: 1

LGR4 is essential for maintaining β-cell homeostasis through suppression of RANK
Joanna Filipowska, Zelda Cisneros, Nancy Leon-Rivera, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1

EXPLORING THE UNINTENDED CONSEQUENCES OF MISUSE OF WEGOVY AND OZEMPIC IN WEIGHT MANAGEMENT: A COMPREHENSIVE REVIEW
SARTHAK A. KUTE, Madhura S. Chothave, PRAJAKTA B. ROTE, et al.
International Journal of Pharmacy and Pharmaceutical Sciences (2024), pp. 10-13
Open Access | Times Cited: 1

Isoquinoline small molecule ligands are agonists and probe-dependent allosteric modulators of the glucagon subfamily of GPCRs
Elita Yuliantie, Phuc N. H. Trinh, Caroline A. Hick, et al.
Biochemical Pharmacology (2024) Vol. 229, pp. 116483-116483
Open Access | Times Cited: 1

Activation of Gs signaling in mouse enteroendocrine K cells greatly improves obesity- and diabetes-related metabolic deficits
Antwi‐Boasiako Oteng, Liu Liu, Yinghong Cui, et al.
Journal of Clinical Investigation (2024) Vol. 134, Iss. 24
Open Access | Times Cited: 1

Glucagon‐Like Peptide‐1 Links Ingestion, Homeostasis, and the Heart
Jean‐Philippe Krieger, Derek Daniels, Shin Lee, et al.
Comprehensive physiology (2024) Vol. 15, Iss. 1
Closed Access | Times Cited: 1

Chronic metabolic stress drives developmental programs and loss of tissue functions in non-transformed liver that mirror tumor states and stratify survival
Constantine N. Tzouanas, Marc S. Sherman, Jessica E.S. Shay, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 4

G protein-coupled receptors and obesity
Alessandro Pocai
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 3

Poly-Agonist Pharmacotherapies for Metabolic Diseases: Hopes and New Challenges
C. Allard, Daniela Cota, Carmelo Quarta
Drugs (2023) Vol. 84, Iss. 2, pp. 127-148
Closed Access | Times Cited: 3

Selective prosaposin expression in Langerhans islets of the mouse pancreas
Aimi Fuyuki, Md. Shahriar Hasan Sohel, Takeshi Homma, et al.
Tissue and Cell (2024) Vol. 88, pp. 102367-102367
Open Access

The Expanding Problem of Regional Adiposity: Revisiting a 1985 Diabetes Classic by Ohlson et al.
Olga T. Gupta, Rana K. Gupta
Diabetes (2024) Vol. 73, Iss. 5, pp. 649-652
Open Access

Fluorescent GLP1R/GIPR dual agonist probes reveal cell targets in the pancreas and brain
David J. Hodson, Anne de Bray, Jason Tong, et al.
Research Square (Research Square) (2024)
Open Access

Neuroprotective Activity of GLP-1 Analogues: General Understanding of Implementation Mechanisms
E. L. Golovina, О. Е. Ваизова, J. G. Samojlova
Personalized Psychiatry and Neurology (2024) Vol. 4, Iss. 3, pp. 2-11
Closed Access

De la découverte des incrétines aux blockbusters coupe-faim. 100 ans de recherches pour arriver sous les feux de l’actualité thérapeutique
Bernard Portha, Junjun Liu, Jamileh Movassat, et al.
Cahiers de Nutrition et de Diététique (2024)
Closed Access

Management of Obesity Disorders in Childhood and Adolescence
Peter Kühnen
Endocrinology (2024), pp. 585-602
Closed Access

Brainstem BDNF neurons are downstream of GFRAL/GLP1R signalling
Claire H. Feetham, Valeria Collabolletta, Amy A. Worth, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access

NEW TREATMENTS FOR OBESITY: DOUBLE AGONIST TWO GIP/ GLP-1 RECEPTORS – TIRZEPATIDE
Gabrielle Molina Pinto, Mariane Csizmar Gonçalves, Pedro Lucas Silveira Duarte, et al.
International Journal of Health Science (2024) Vol. 4, Iss. 12, pp. 2-9
Open Access

Scroll to top